Bluejay Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Bluejay Diagnostics, Inc. (BJDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 32 shares for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-11-07
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 3.00 shares.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 2.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-09-30 | 3.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 32.00 shares 10-Q · filed 2025-11-07 | ||
| 2025-06-30 | 29.00 shares 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | 2.00 shares 10-K · filed 2025-03-31 | |||
| 2021-09-30 | 8.65K shares 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |